such as simple srjirometry, as well as more complete testing including lung volumes, intrapulmonary gas distribution and arterial blood gas determinations, have been reported to be useful in the identification and therapy of early and often asymptomatic lung disease. 1-5 Consequently, pulmonary function tests are now widely used to quantitate and qualitate lung dysfunction, as well as to evaluate potential reversibility. Most clinicians agree that patients with respiratory impairment due to clinically obvious chronic lung disease are at increased risk of having intraoperative and/or postoperative complications. The value of quantitating the degree of abnormality present in order to assess postoperative risk is unknown except prior to lung resection. 6 This is especially true in the evaluation of patients prior to elective cardiovascular surgery which does not involve lung resection and for which the decision to operate has not been precluded by the coexistence of clinically severe lung disease. Despite previous suggestions by Comroe and others 2 -7 ' 8 that quantitative pulmonary function limits were of little value in an individual patient, efforts have continued to establish such limits and preoperative pulmonary function tests are performed routinely in many hospitals in this country. With the recent surge in cardiovascular surgery, there has been increased interest in the relationship between preoperative pulmonary function and postoperative risk among patients undergoing thoracic and upper abdominal cardiovascular corrective procedures. This study was undertaken to assess the role of such tests in these situations.
"Preoperative pulmonary function testing (PFT)
such as simple srjirometry, as well as more complete testing including lung volumes, intrapulmonary gas distribution and arterial blood gas determinations, have been reported to be useful in the identification and therapy of early and often asymptomatic lung disease. [1] [2] [3] [4] [5] Consequently, pulmonary function tests are now widely used to quantitate and qualitate lung dysfunction, as well as to evaluate potential reversibility. Most clinicians agree that patients with respiratory impairment due to clinically obvious chronic lung disease are at increased risk of having intraoperative and/or postoperative complications. The value of quantitating the degree of abnormality present in order to assess postoperative risk is unknown except prior to lung resection. 6 This is especially true in the evaluation of patients prior to elective cardiovascular surgery which does not involve lung resection and for which the decision to operate has not been precluded by the coexistence of clinically severe lung disease. Despite previous suggestions by Comroe and others 2 -7 ' 8 that quantitative pulmonary function limits were of little value in an individual patient, efforts have continued to establish such limits and preoperative pulmonary function tests are performed routinely in many hospitals in this country. With the recent surge in cardiovascular surgery, there has been increased interest in the relationship between preoperative pulmonary function and postoperative risk among patients undergoing thoracic and upper abdominal cardiovascular corrective procedures. This study was undertaken to assess the role of such tests in these situations.
MATERIALS AND METHODS
The records of 106 patients who were admitted to the Cardiovascular Surgery Service of The Methodist Hospital and who had had preoperative pulmonary function tests within four weeks prior to major cardiovascular surgery were selected randomly for detailed analysis. Although a larger number of records was reviewed to obtain a population meeting these selection criteria, there were no records which indicated that patients had been denied surgery on the basis of the type or severity of impairment of pulmonary function. The criteria upon which patients were selected for these tests before operation were almost exclusively based upon clinical judgment regarding need to document severity, and to determine gas exchange consequences of lung disease.
All tests were performed using an Ohio 840 rolling-seal spirometer in line with a PDP-12 computer for direct data reduction of expiratory and inspiratory volumes and flows. Functional residual capacity and airway resistance were determined using an Ohio 3000 pressure-sensitive whole body plethysmograph. Arterial blood gas tensions were measured using Instrument Laboratory or Radiometer blood gas analyzers. Predicted normal levels were taken from the regression equations of Morris et al 9 
RESULTS

Definition of Study Groups
Analysis of historic data, incidence of postoperative complications and preoperative pulmonary function showed similar results at 4,5, or 8 day stays in the ICU after operation. Therefore, detailed description of patients only with an ICU stay greater or less than five days will be presented.
The mean ICU time for all patients was 4.5 days (range 1-36). Group 1 patients (71 percent) were in the ICU for less than five days, with a mean stay of 2.7 days. Group 2 included the remaining patients who were in the ICU for five or more days with a mean time of 7.3 days (Fig I) . Patients in group 2 were older and before operation had a higher incidence of cough, but smoking history and the incidence of sputum production and dyspnea prior to surgery were similar in both groups (Table 1) . Coronary artery bypass (CAB) was the most frequently performed procedure, and 17 percent of these patients had a prolonged ICU stay. Relative to surgery for coronary artery bypass, the incidence or prolonged ICU stay was similar following abdominal aortic aneurysm (AAA), peripheral vascular (PV), and cardiovalvular (valve) surgery. Only following surgery for thoracic aortic aneurysm (TAA) was a prolonged ICU stay significantly more frequent ( Table 2 ). incidences of atelectasis, renal insufficiency and gastrointestinal bleeding were greater among patients in group 2 ( Table 3) . Five of the six deaths occurred following repair of aortic aneurysm, but no death was directly due to pulmonary causes. Mean anesthesia time (210 ± 74.9 minutes), mean cardiopulmonary bypass time (where applicable) (64 ± 26.3 minutes) and mean time to extubation (16 ± 5.9 hours) in group 1 were statistically similar to that of group 2 and there was no relationship between individual lengths of time and postoperative complications.
Relationship of Complications to PFT
Qualitative classifications of preoperative pulmonary function testing indicated that 93 percent of the patients were considered abnormal, with 90 percent having an obstructive defect and 10 percent a restrictive defect. Only 30 percent of patients with abnormal PFT stayed in the ICU longer than five days, regardless of the type of abnormality. Quantitative analysis of preoperative PFT parameters for the two groups indicated that patients in group 2 had lower FVC (percent predicted), FEVi, FEF25-75, PEFR (percent predicted) than patients in group 1 (Table 4) . Although there was no differ- ence in the mean arterial PCO2 between groups 1 and 2, the four patients who had an arterial PCO2 level greater than 45 mm Hg preoperatively were all in group 2 and two of these died.
In an attempt to define quantitative limits of pulmonary function impairment that would be of predictive value for postoperative problems, we compared the postoperative course of patients with moderate dysfunction to that of patients with severe abnormalities. Analysis of several parameters commonly used in evaluating preoperative pulmonary function failed to show any difference in the mean length of ICU stay or incidence of complications. Thus, the postoperative course of patients with an FEVi of < 1 L did not differ from that of patients with an FEVi of > 2 L. Similarly, no difference could be found between patients with an FVC less than or greater than 60 percent of predicted, or an MVV less than 40 percent predicted as compared to greater than 60 percent predicted (Fig 2) . Even pulmonary complications such as atelectasis could not be correlated with the degree or preoperative PFT abnormality since there was no difference in the mean preoperative function of patients who developed it and those who did not (Table 5) . How- ever, the incidence of atelectasis was directly related to the type of surgical procedure, with 100 percent incidence following TAA resection as compared to only 48 percent after PV surgery (P < .01); the incidence of atelectasis after coronary bypass {58 percent), abdominal aortic (70 percent), and valve aneurysm surgery (82 percent) was statistically the same as for peripheral vascular surgery.
Influence of Therapy
In order to assess the effects of preoperative therapy and the postoperative course of patients with severe abnormalities detected on tests of pulmonary function, we evaluated the length of ICU stay in patients with FEVi < 1.5 L who were so treated as compared with similarly impaired patients who were not (Table6). In spite of very similar results of preoperative pulmonary function tests, there were Figure 2 . Correlation of specific levels of obstruction and postoperative complications. The mean ICU stay (days) of patients with severe disease was similar to that of patients with moderate disease. * = mean ± SD **NS = not significant no differences in ICU stay, whether bronchodilator drugs, IPPB, or chest physiotherapy were or were not used preoperatively.
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DISCUSSION
Obviously, many factors other than preoperative pulmonary function test results affect complications after thoracic or abdominal surgery. 14 These include variations in surgical skill and in postoperative care which may account for the increasing willingness of surgeons to operate on aged patients with cardiopulmonary disorders, even when severe functional impairment has been delineated. These factors will affect the outcome of any study and may affect even more the outcome of this study which deals specifically with cardiovascular surgery and its unique technical, anesthetic, and cardiopulmonary physiologic facets. There have been some recent suggestions regarding the selection of specific limits of pulmonary function tests in the assessment of risks after noncardiovascular thoracic surgery, 15 " 17 but there is no literature which considers specific minimal criteria for predicting risk of complications after cardiovascular surgery. The frequency with which this type of surgery is performed would seem to demand vigorous efforts to identify which test, if any, is most useful in the prediction of excessive morbidity and mortality from postoperative respiratory problems.
Although the absence of symptoms does not preclude the presence of significant lung disease, our data suggest that the presence of cough or advanced age are associated with significantly greater risk of postoperative complications. The presence of other respiratory symptoms may not be helpful, perhaps as a result of their lesser specificity for primary lung disease.
Our physiologic data confirm the findings of Milledge and Nunn 18 who showed that only preoperative arterial hypercapnia (PaC02 > 50 mm Hg) correlated with the development of major postoperative problems while marked reductions in expiratory flow such as an FEVi 0.4 1.2 L, did not. They concluded that the severity of functional impairment per se was of no predictive value, but when severe dysfunction was present, it should be investigated further with arterial blood gas determinations. Although our patients with postoperative complications had more abnormal findings before surgery than patients without complications, quantitating the degree of abnormality was of no value in predicting an increase in risk for postoperative complications. Only the presence of carbon dioxide retention uniformly portended an ominous prognosis.
It is generally recommended that tests of pulmonary function should be an integral part of the preoperative evaluation whenever there is any suspicion of lung disease or when major abdominal or resectional thoracic surgery are planned. The fact that thoracic and high abdominal surgery carry the highest attendant risk of postoperative morbidity and mortality in patients with respiratory dysfunction 19 has led to the assumption that quantitation of such must be important. This assumption may not be valid since, as shown in this study, postoperative complications may be determined more by the type of cardiovascular surgery rather than by preoperative pulmonary function status. This fact applied to all complications collectively, as well as specifically to the occurrence of pulmonary complications. Surgery for aortic aneurysm, especially thoracic, was associated with the greatest postoperative morbidity (46 percent of patients) as well as 83 percent of postoperative deaths. The important role of type of surgery is supported further by the finding of essentially the same degree of preoperative pulmonary dysfunction among the patients undergoing the various procedures. There are probably no lower limits of pulmonary function which preclude emergency surgery, and these data suggest that there may be no such limits even for elective high abdominal or thoracic-cardiovascular surgery, once clinical judgment has ascertained that a patient is otherwise a suitable candidate for the procedure and that he has no hypercapnia. In addition, the availability of high quality postoperative care in intensive care units may negate the influence of poor preoperative pulmonary function.
These data also suggest that pulmonary function tests as a means of detecting airway disease before operation and then treating airway disease may not be justifiable. Mean test results were essentially the same in the patients for whom no therapy was instituted as it was in those who were treated. This fact does not preclude the usefulness and beneficial effects of preoperative respiratory therapy, but rather suggests that clinical assessment is a more rational basis for therapy rather than the results of pulmonary function tests. Hence, the use of preoperative pulmonary function tests for assessing reversible disease can be challenged, since many patients with irreversible disease, as determined by objective pulmonary function tests, are given therapeutic trials and operated on regardless of whether they improve or not; conversely, some patients with reversible disease have surgery without any preoperative therapy. This common practice implies that pulmonary function test results may not be indispensable in preoperative evaluation, particularly when the patient has detectable airway obstruction by physical examination.
We conclude that there is little value in routinely and elaborately quantitating clinically apparent pulmonary dysfunction prior to cardiovascular surgery. The only mitigating qualification to this conclusion would seem to be that this "testing" approach subserves a diagnostic purpose when physicians, for whatever reasons, fail to meet appropriate responsibilities of history-taking and examination. If tests of pulmonary function are desired, only spirometric tests may be necessary to document the presence of dysfunction, while measurement of arterial blood gas levels to exclude carbon dioxide retention is prognostically important and therefore justifiable. These considerations suggest that the most important information in preoperative evaluation is the clinical impression of the physicians involved and not the preoperative pulmonary function test results. Traditional dogma regarding the necessity for preoperative pulmonary function tests has led to great hesitancy among physicians to admit this fact. As a consequence, there is continued use of testing which has definite value in many situations, but perhaps not in the preoperative assessment of patients admitted for cardiovascular surgery. While there may be some alarming economic ramifications to these conclusions, maintenance of the proper scientific and intellectual integrity requires validation or refutation of these findings. Otherwise, as implied by Guenter, 20 "a spring in the step and a glint in the eye" may well be more predictive of postoperative course than elaborately-quantitated preoperative pulmonary function tests.
